Home Data Calendar Blog

SERA

Tables

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Weighted Average Number Of Diluted Shares Outstanding		NA	31.29	31.08	31.02	NA	31.01	30.95	30.80	NA	25.09	0.95	0.86	NA	0.74	NA
Weighted Average Number Of Shares Outstanding Basic		NA	31.29	31.08	31.02	NA	31.01	30.95	30.80	NA	25.09	0.95	0.86	NA	0.74	NA
Earnings Per Share Basic		-0.25	-0.23	-0.34	-0.34	-0.32	-0.35	-0.37	-0.40	-0.01	-0.39	-6.60	-7.40	-6.88	-6.88	NA
Earnings Per Share Diluted		-0.25	-0.23	-0.34	-0.34	-0.32	-0.35	-0.37	-0.40	-0.01	-0.39	-6.60	-7.40	-6.88	-6.88	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Revenue From Contract With Customer Excluding Assessed Tax		0.04	0.04	0.12	0.10	0.07	0.09	0.08	0.04	0.03	0.02	0.02	0.01	0.01	0.01	0.01
Revenues		0.04	0.04	0.12	0.10	0.07	0.09	0.08	0.04	0.03	0.02	0.02	0.01	0.01	0.01	0.01
Operating Expenses		8.89	8.23	11.58	11.43	10.48	11.28	11.82	12.34	12.57	9.46	7.40	6.04	4.76	4.65	4.29
Research And Development Expense		3.90	3.54	3.69	4.10	3.48	4.18	3.26	3.32	3.08	2.72	2.82	2.40	2.09	1.89	1.75
General And Administrative Expense		3.67	3.29	4.94	4.45	3.88	4.07	4.29	4.54	4.94	4.04	2.83	2.29	1.65	1.70	1.82
Selling And Marketing Expense		1.30	1.35	2.87	2.82	3.06	2.97	4.22	4.46	4.55	2.69	1.74	1.35	1.01	1.05	0.71
Operating Income Loss		-8.85	-8.18	-11.46	-11.33	-10.42	-11.19	-11.75	-12.30	-12.55	-9.44	-7.38	-6.03	-4.75	-4.64	-4.28
Interest Expense		NA	0.01	0.01	0.02	NA	0.02	0.02	0.00	NA	0.44	-0.00	0.31	NA	NA	NA
Interest Paid Net		0.01	0.01	0.01	0.02	0.02	0.02	0.01	0.00	-0.09	0.00	-0.01	1.28	0.04	0.06	NA
Allocated Share Based Compensation Expense		1.35	1.18	1.44	1.30	1.34	1.28	1.21	1.22	1.11	0.91	0.86	0.24	0.20	0.20	0.20
Other Comprehensive Income Loss Net Of Tax		0.60	0.06	-0.21	0.52	0.19	-0.35	-0.16	-0.47	-0.16	-0.03	NA	NA	NA	NA	NA
Net Income Loss		-7.92	-7.21	-10.54	-10.56	-9.75	-10.71	-11.52	-12.21	-12.48	-9.86	-6.31	-6.36	-5.38	-5.07	-4.71
Comprehensive Income Net Of Tax		-7.33	-7.15	-10.76	-10.04	-9.56	-11.06	-11.68	-12.68	-12.64	-9.88	-6.31	-6.36	-5.38	-5.07	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Assets		95.44	90.06	96.68	105.61	116.33	116.56	125.06	134.87	147.03	153.69	95.07	NA	14.80	NA	NA
Liabilities		25.28	14.65	15.54	15.40	17.39	9.40	8.15	7.66	8.46	3.65	3.88	NA	12.33	NA	NA
Liabilities And Stockholders Equity		95.44	90.06	96.68	105.61	116.33	116.56	125.06	134.87	147.03	153.69	95.07	NA	14.80	NA	NA
Stockholders Equity		70.16	75.41	81.14	90.21	98.94	107.16	116.91	127.20	138.56	150.04	-135.80	-130.39	-125.57	-120.49	-115.69

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Assets Current		61.34	47.55	64.43	72.11	90.12	90.84	108.05	109.47	110.25	122.34	91.37	NA	13.73	NA	NA
Cash And Cash Equivalents At Carrying Value		3.88	9.65	32.28	27.20	29.88	38.81	53.89	64.08	58.93	82.48	90.85	NA	13.53	NA	NA
Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents		3.88	9.65	32.28	27.20	29.88	38.81	53.89	64.08	58.93	82.48	90.85	60.02	13.53	18.68	23.63
Marketable Securities Current		45.20	36.46	31.54	43.59	52.83	49.97	53.02	43.47	46.18	37.50	NA	NA	NA	NA	NA
Accounts Receivable Net Current		0.16	0.15	0.16	0.12	0.11	0.11	0.07	0.04	0.03	0.04	0.01	NA	0.00	NA	NA
Prepaid Expense And Other Assets Current		0.80	1.27	0.44	1.20	1.31	1.95	1.01	1.88	1.99	2.33	0.50	NA	0.20	NA	NA
Available For Sale Securities Debt Securities		76.04	75.38	59.84	72.50	74.16	72.35	66.70	65.80	81.00	67.50	NA	NA	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Indefinite Lived Intangible Assets Excluding Goodwill		NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA
Other Assets Noncurrent		1.26	1.39	1.53	1.68	1.82	0.24	0.36	0.49	0.16	0.17	2.83	NA	0.10	NA	NA
Available For Sale Debt Securities Amortized Cost Basis		76.05	76.00	60.51	72.96	75.13	73.51	67.51	66.45	81.21	67.52	NA	NA	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Liabilities Current		24.44	13.54	14.18	13.80	15.54	8.67	7.30	6.94	8.41	3.54	3.23	NA	11.24	NA	NA
Accounts Payable Current		1.05	1.18	1.24	1.59	1.55	1.09	0.78	0.94	1.20	1.27	1.03	NA	0.44	NA	NA
Other Accrued Liabilities Current		0.93	0.74	0.65	0.66	0.64	0.32	0.60	0.53	0.93	0.13	0.17	NA	0.19	NA	NA
Contract With Customer Liability Current		20.23	9.04	9.05	9.07	9.08	3.09	3.10	3.11	3.12	NA	NA	NA	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Operating Lease Liability Noncurrent		0.64	0.79	0.94	1.08	1.22	NA	NA	NA	NA	NA	NA	NA	NA	NA	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Stockholders Equity		70.16	75.41	81.14	90.21	98.94	107.16	116.91	127.20	138.56	150.04	-135.80	-130.39	-125.57	-120.49	-115.69
Additional Paid In Capital		317.07	314.99	313.57	311.88	310.57	309.23	307.92	306.53	305.21	304.04	8.33	NA	5.89	NA	NA
Retained Earnings Accumulated Deficit		-246.90	-238.97	-231.76	-221.22	-210.65	-200.91	-190.20	-178.68	-166.47	-153.98	-144.12	NA	-131.46	NA	NA
Accumulated Other Comprehensive Income Loss Net Of Tax		-0.01	-0.61	-0.67	-0.46	-0.98	-1.17	-0.82	-0.66	-0.18	-0.03	NA	NA	NA	NA	NA
Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value		NA	1.18	1.44	1.30	NA	1.28	1.21	1.22	NA	0.91	0.86	0.24	NA	0.20	0.20

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Net Cash Provided By Used In Operating Activities		-6.76	-7.59	-7.95	-4.88	-7.24	-8.78	-9.04	-9.56	-9.15	-9.30	-6.24	-6.95	-4.18	-3.92	NA
Net Cash Provided By Used In Investing Activities		0.37	-15.16	12.91	2.32	-1.58	-6.30	-1.21	14.63	-14.43	-68.00	-0.09	-0.04	-0.04	-0.08	NA
Net Cash Provided By Used In Financing Activities		0.62	0.13	0.12	-0.12	-0.12	-0.01	0.06	0.07	0.04	68.92	37.16	53.47	-0.92	-0.94	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Net Cash Provided By Used In Operating Activities		-6.76	-7.59	-7.95	-4.88	-7.24	-8.78	-9.04	-9.56	-9.15	-9.30	-6.24	-6.95	-4.18	-3.92	NA
Net Income Loss		-7.92	-7.21	-10.54	-10.56	-9.75	-10.71	-11.52	-12.21	-12.48	-9.86	-6.31	-6.36	-5.38	-5.07	-4.71
Depreciation Depletion And Amortization		0.21	0.20	0.20	0.24	0.20	0.20	0.20	0.17	0.14	0.10	0.20	0.20	0.20	0.20	0.20
Increase Decrease In Accounts Receivable		0.01	-0.01	0.04	0.01	0.01	0.03	0.03	0.01	-0.01	0.02	0.01	0.01	0.00	NA	NA
Increase Decrease In Accounts Payable		-0.18	0.03	-0.28	-0.01	0.56	0.28	-0.23	-0.25	0.09	0.32	-0.14	0.34	-0.14	0.12	NA
Share Based Compensation		1.35	1.18	1.44	1.30	1.34	1.28	1.21	1.22	1.11	0.91	0.86	0.24	0.20	0.20	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Net Cash Provided By Used In Investing Activities		0.37	-15.16	12.91	2.32	-1.58	-6.30	-1.21	14.63	-14.43	-68.00	-0.09	-0.04	-0.04	-0.08	NA
Payments To Acquire Property Plant And Equipment		0.02	0.03	0.05	0.04	0.19	0.37	0.22	0.01	0.75	0.43	0.09	0.04	0.04	0.08	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Net Cash Provided By Used In Financing Activities		0.62	0.13	0.12	-0.12	-0.12	-0.01	0.06	0.07	0.04	68.92	37.16	53.47	-0.92	-0.94	NA

		2023-12-31	2023-09-30	2023-06-30	2023-03-31	2022-12-31	2022-09-30	2022-06-30	2022-03-31	2021-12-31	2021-09-30	2021-06-30	2021-03-31	2020-12-31	2020-09-30	2020-06-30
Revenues		0.04	0.04	0.12	0.10	0.07	0.09	0.08	0.04	0.03	0.02	0.02	0.01	0.01	0.01	0.01
Elevance Health Inc, Investor, Laboratory Services Agreement		0.01	0.01	NA	0.02	0.04	0.02	NA	NA	NA	NA	NA	NA	NA	NA	NA
Revenue From Contract With Customer Excluding Assessed Tax		0.04	0.04	0.12	0.10	0.07	0.09	0.08	0.04	0.03	0.02	0.02	0.01	0.01	0.01	0.01
Elevance Health Inc, Investor, Laboratory Services Agreement		0.01	0.01	NA	0.02	0.04	0.02	NA	NA	NA	NA	NA	NA	NA	NA	NA

Plots across concepts

Line plots across dimensions of each concept